Cumulative Event Rates Among Patients at First (A) and Second (B) Sickle Cell-Related Pain Episodes. From N Engle J Med, Ataga KI et al, Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease, Volume 376, Page 429-39. Copyright © 2017 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.